Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-2006 | 03-2006 | 01-2006 | 12-2005 | 10-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -3,150 | -2,280 | -2,280 |
| Depreciation Amortization | N/A | 1,440 | 1,445 | 1,150 | 1,150 |
| Accounts receivable | N/A | N/A | -31 | N/A | 0 |
| Other Working Capital | N/A | -150 | -195 | -150 | -150 |
| Other Operating Activity | 0 | 20 | 97 | -10 | -10 |
| Operating Cash Flow | $N/A | $1,310 | $-1,835 | $-1,290 | $-1,290 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -20 | -22 | -10 | -10 |
| Other Investing Activity | 0 | 0 | -32 | -20 | -20 |
| Investing Cash Flow | $N/A | $-20 | $-54 | $-30 | $-30 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,131 | N/A | 0 |
| Common Stock Issued | N/A | N/A | 322 | N/A | 0 |
| Other Financing Activity | 0 | 1,450 | 0 | 1,450 | 1,450 |
| Financing Cash Flow | $N/A | $1,450 | $1,452 | $1,450 | $1,450 |
| Beginning Cash Position | N/A | N/A | 589 | 580 | 580 |
| End Cash Position | N/A | N/A | 153 | 710 | 710 |
| Net Cash Flow | $N/A | $2,740 | $-436 | $120 | $120 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 1,310 | -1,835 | -1,290 | -1,290 |
| Capital Expenditure | N/A | N/A | -22 | N/A | 0 |
| Free Cash Flow | 0 | 1,310 | -1,856 | -1,290 | -1,290 |